Back to News
Market Impact: 0.22
Wall Street Analysts See a 26.72% Upside in Biodesix (BDSX): Can the Stock Really Move This High?
Source: zacks.com
Analyst InsightsAnalyst EstimatesCompany FundamentalsInvestor Sentiment & Positioning
Biodesix (BDSX) faces potential 26.7% upside implied by the consensus price target, though the article notes this metric is not a strong predictor. The main near-term catalyst cited is an upward trend in earnings estimate revisions, which could support additional stock upside.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.12
Ticker Sentiment
BDSX0.25
More News
- Treasuries Soar as Tech Slump Threatens Growth
- CoreWeave credit default swaps hit distress levels as investors sour on AI debt
- Brian Sullivan: Why the 'real' price of oil is likely $30-$40 higher than where it is now
- Penske Automotive agrees to be taken private by Penske, Mitsui
- Supermicro promised a new CFO in December 2024. A $2.5 billion smuggling case and a co-founder’s arrest later, it has one
- Blackstone President Jon Gray Bets Big on AI Boom